Answer
Wegovy (semaglutide) has no or negligible influence on driving or machinery use, but dizziness, mainly during dose escalation, warrants caution; patients with type 2 diabetes using insulin or a sulfonylurea alongside semaglutide should take precautions against hypoglycaemia when driving or using machines.
Sources for this answer
- Wegovy 2.4 mg, FlexTouch solution for injection in pre-filled penNovo Nordisk Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 16Document updated
Sources checked